Metraipolis › archive › dc_c2f4a6be5bcb

CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies — Europe PMC PMID:41754959

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754959
DOI
10.3390/pharmaceutics18020217
License (as archived)
solo-consultazione
Archived
2026-11-06T00:32:19.576Z
SHA-256 of the archived text
c98eafe9ea023a50dc2eaffd9575a1d8656b098470e80d2e0766cfc59602f546
Stable URL of this page
https://metraipolis.com/documento/dc_c2f4a6be5bcb

How to cite

CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies — Europe PMC PMID:41754959 — Europe PMC (en), https://europepmc.org/article/MED/41754959 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2f4a6be5bcb (Metraipolis archive dc_c2f4a6be5bcb, sha256 c98eafe9ea023a50dc2eaffd9575a1d8656b098470e80d2e0766cfc59602f546)
BibTeX
@misc{dcc2f4a6be5bcb,
  title = {CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies — Europe PMC PMID:41754959},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754959},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2f4a6be5bcb; sha256 c98eafe9ea023a50dc2eaffd9575a1d8656b098470e80d2e0766cfc59602f546},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754959. Agents can read the archived copy with the MCP tool read_document.